Dr. Amanda A. Lloyd, MD

Dr. Lloyd practices at UCSD Center for Surgery of Encinitas in Encinitas, California.

Dr. Lloyd's NPI, 1740593664, was assigned on July 20, 2010. Dr. Lloyd graduated from The Robert Larner, M.D. College of Medicine in 2010. Dr. Lloyd holds California license A123852.

Dr. Lloyd's primary practice is UCSD Center for Surgery of Encinitas, at 477 N El Camino Real Suite C-100, Encinitas, CA 92024. The practice phone is (760) 942-8800.

Dr. Lloyd's primary practice is UCSD Center for Surgery of Encinitas in Encinitas, California. Dmand AI also links Dr. Lloyd to 1 physician office and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lloyd practices, 3 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Lloyd's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Lloyd is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Lloyd's licenses on file in 4 states: California, South Dakota, Texas and Illinois.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, contact dermatitis, itchy rashes, psoriasis and rash among the conditions Dr. Lloyd treats.

CMS data shows 3,563 Medicare services from Dr. Lloyd across 23 procedure codes in 2024, for 293 Medicare patients. Medicare paid $282,772 for them. Every service was in an office.

CMS counts 293 Medicare patients who saw Dr. Lloyd in 2024. The largest group is 65 to 74, with 162 patients. 73% of them have high cholesterol, and 50% have high blood pressure. Their average risk score is 0.79, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Lloyd's median patient age at 69, with 64% women.

In 2024, Dr. Lloyd wrote 282 Medicare Part D claims for 140 patients. 99% of them were for generic drugs. CMS names the drug for 229 of them, across 7 drugs with 11 or more claims each, at $7,271 in total drug cost. In 2023, CMS named 163 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Lloyd for performance year 2024, reported individually. Dr. Lloyd accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lloyd as offering telehealth. CMS counts 565 procedures of skin biopsy by Dr. Lloyd, more than 96% of the clinicians it reports for that procedure.

Dmand AI links 8 papers to Dr. Lloyd, published from 2014 to 2015. 2015 was the busiest year, with 3. The most frequent topics are Skin Neoplasms, Administration, Topical and Carcinoma, Squamous Cell. Dr. Lloyd has published most often in Dermatol Surg. Dr. Lloyd's most frequent co-authors are Michael Stephen Graves, MD, Edward Victor Ross, MD and Goran B. G. Klintmalm, MD.

CMS Open Payments shows 281 general payments to Dr. Lloyd from 53 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 88% of the total. Abbvie Inc. paid the most, $64,962.

Dmand AI lists 11 awards for Dr. Lloyd, most recently Third Place Award in 2013.

Dr. Lloyd graduated from The Robert Larner, M.D. College of Medicine in 2010.

Dr. Lloyd is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.